au.\*:("MASON, Malcolm")
Results 1 to 25 of 33
Selection :
What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care?MASON, Malcolm.Journal of cancer research and clinical oncology. 2006, Vol 132, issn 0171-5216, S27-S35, SUP1Article
The interaction between β-catenin, GSK3β and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancerDAVIES, Gaynor; JIANG, Wen G; MASON, Malcolm D et al.International journal of oncology. 2001, Vol 18, Num 4, pp 843-847, issn 1019-6439Article
Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells : A key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasionDAVIES, Gaynor; JIANG, Wen G; MASON, Malcolm D et al.Clinical cancer research. 2001, Vol 7, Num 10, pp 3289-3297, issn 1078-0432Article
Cell adhesion molecules and adhesion abnormalities in prostate cancerMASON, Malcolm D; DAVIES, Gaynor; JIANG, Wen G et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 1, pp 11-28, issn 1040-8428Article
Understanding the impact of public policy on cancer research: A bibliometric approachLEWISON, Grant; PURUSHOTHAM, Arnie; MASON, Malcolm et al.European journal of cancer (1990). 2010, Vol 46, Num 5, pp 912-919, issn 0959-8049, 8 p.Article
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialWARDE, Padraig; MASON, Malcolm; BARBER, Jim et al.Lancet (British edition). 2011, Vol 378, Num 9809, pp 2104-2111, issn 0140-6736, 8 p.Article
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate CancerMOTTET, Nicolas; BELLMUNT, Joaquim; HEIDENREICH, Axel et al.European urology. 2011, Vol 59, Num 4, pp 572-583, issn 0302-2838, 12 p.Article
Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesotheliomaJASANI, Bharat; COLEMAN, Sharon; BUTCHART, Eric et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2399-2402, issn 0264-410X, 4 p.Conference Paper
A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder CancerMEEKS, Joshua J; BELLMUNT, Joaquim; STERNBERG, Cora N et al.European urology. 2012, Vol 62, Num 3, pp 523-533, issn 0302-2838, 11 p.Article
Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancerDE BONO, Johann Sebastian; BELLMUNT, Joaquim; COCKEY, Louise et al.Journal of clinical oncology. 2007, Vol 25, Num 3, pp 257-262, issn 0732-183X, 6 p.Article
Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancerSUN, Ping-Hui; LIN YE; MASON, Malcolm D et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 7, pp 1129-1139, issn 0171-5216, 11 p.Article
The influence of matriptase-2 on prostate cancer in vitro: A possible role for β-cateninWEBB, Siobhan L; SANDERS, Andrew J; MASON, Malcolm D et al.Oncology reports. 2012, Vol 28, Num 4, pp 1491-1497, issn 1021-335X, 7 p.Article
Gemcitabine chemotherapy for the treatment of metastatic bladder carcinomaSHELLEY, Michael D; CLEVES, Anne; WILT, Timothy J et al.BJU international (Papier). 2011, Vol 108, Num 2, pp 168-179, issn 1464-4096, 12 p.Article
Cancer Exosomes Trigger Fibroblast to Myofibroblast DifferentiationWEBBER, Jason; STEADMAN, Robert; MASON, Malcolm D et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9621-9630, issn 0008-5472, 10 p.Article
The role of surgery in high-risk localised prostate cancerGNANAPRAGASAM, Vincent J; MASON, Malcolm D; SHAW, Greg L et al.BJU international (Papier). 2012, Vol 109, Num 5, pp 648-658, issn 1464-4096, 11 p.Article
EPLIN is a Negative Regulator of Prostate Cancer Growth and InvasionSANDERS, Andrew J; MARTIN, Tracey A; LIN YE et al.The Journal of urology. 2011, Vol 186, Num 1, pp 295-301, issn 0022-5347, 7 p.Article
The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cellsJIANG, Wen G; LIN YE; ABLIN, Richard J et al.International journal of oncology. 2010, Vol 37, Num 2, pp 413-418, issn 1019-6439, 6 p.Article
Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathwayJIANG, Wen G; LIN YE; KE JI et al.International journal of oncology. 2012, Vol 41, Num 5, pp 1635-1642, issn 1019-6439, 8 p.Article
Increased exosome production from tumour cell cultures using the Integra CELLine Culture SystemMITCHELL, J. Paul; COUN, Jacqueline; MASON, Malcolm David et al.Journal of immunological methods. 2008, Vol 335, Num 1-2, pp 98-105, issn 0022-1759, 8 p.Article
The Clinical Management of Patients With a Small Volume of Prostatic Cancer on Biopsy : What Are the Risks of Progression? A Systematic Review and Meta-analysisHARNDEN, Patricia; NAYLOR, Brian; SHELLEY, Michael D et al.Cancer. 2008, Vol 112, Num 5, pp 971-981, issn 0008-543X, 11 p.Article
Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancerCOLEMAN, Sharon; CLAYTON, Aled; MASON, Malcolm D et al.Cancer research (Baltimore). 2005, Vol 65, Num 15, pp 7000-7006, issn 0008-5472, 7 p.Article
HAVcR-1 Reduces the Integrity of Human Endothelial Tight JunctionsMARTIN, Tracey A; HARRISON, Gregory M; MASON, Malcolm D et al.Anticancer research. 2011, Vol 31, Num 2, pp 467-473, issn 0250-7005, 7 p.Article
Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic reviewSHELLEY, Mike D; JONES, Gabriel; CLEVES, Anne et al.BJU international (Papier). 2012, Vol 109, Num 4, pp 496-505, issn 1464-4096, 10 p.Article
Phospholipase-C gamma-1 (PLCy-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cellsDAVIES, Gaynor; MARTIN, Tracey A; LIN YE et al.Urologic oncology. 2008, Vol 26, Num 4, pp 386-391, issn 1078-1439, 6 p.Article
A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinomaSKYRME, Rob J; FRENCH, A. Jane; DATTA, Shibendra N et al.BJU international (Papier). 2005, Vol 95, Num 9, pp 1206-1210, issn 1464-4096, 5 p.Article